Business
Alternate Health CEO comments on undervalued stock, releases revised 2018 revenue projection
Alternate Health CEO comments on undervalued stock, releases revised 2018 revenue projection.
About this update from Alternate Health Corp
[{"type":"text","content":"\n\n\n\nAlternate Health CEO comments on undervalued stock, releases revised 2018 revenue projection\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prngen5{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prngen4{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n\n\n\n\n\n\nAlternate Health CEO comments on undervalued stock, releases revised 2018 revenue projection\nCanada NewsWire\nSAN ANTONIO, TX, March 7, 2018\n\n\n\nSAN ANTONIO, TX, March 7, 2018 /CNW/ - Alternate Health Corp. (\"Alternate Health\" or the \"Company\") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated company providing software solutions and laboratory services to the medical cannabis industry, today announced the release of revised revenue projections for 2018 demonstrating a positive outlook for the next 12 months.\n\n\n \n \n\n \n\"Alternate Health experienced two main delays at the end of 2017, which prevented the company from reaching our anticipated revenue targets,\" says Dr. Michael Murphy, Chairman and CEO of Alternate Health. \"However, we have had a bright start to 2018 and we expect we will reach a $75 million revenue target by the end of this fiscal year with only a one quarter delay.\"\n\n\n\n\nREVISED AHG 12 MONTH PROJECTIONS: Q1 2018 – Q4 2018*\n\n\n\nTotal Net Revenue: $73,083,000\n\n\n\nTotal EBITDA: $33,410,000\n\n\n\n\n\n\n\nDate\n\n\nNet Revenue\n\n\nEBITDA\n\n\n\nQ1 2018\n\n\n...